1-4 of 4
Robert C. Wolf, PharmD
Close
Sort by
Journal Articles

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Fevzi Yalniz, MD, Mehrdad Hefazi, MD, Kristen B. McCullough, PharmD, Mark Litzow, MD, William J Hogan, MBChB, Robert C Wolf, PharmD, Hassan B Alkhateeb, MD, Ankit Kansagra, Moussab Damlaj, MD, Mrinal M Patnaik, MBBS
Journal: Blood
Blood (2016) 128 (22): 4593.
https://doi.org/10.1182/blood.V128.22.4593.4593
Published: 2016
Journal Articles

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Daniel K. Partain, MD, Jehad Almasri, MD, Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD, Dennis A. Gastineau, MD, Aref Al-Kali, MD, Robert C Wolf, PharmD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS
Journal: Blood
Blood (2015) 126 (23): 736.
https://doi.org/10.1182/blood.V126.23.736.736
Published: 2015
Journal Articles

Development of an Online Patient Decision Aid for Previously Treated Mantle Cell Lymphoma

Thomas W. LeBlanc, MD MA, Robert C Wolf, PharmD, Ellen Neylon, NP, Valerie Caroselli, Katie Deering, Brad Schenkel, MSc
Journal: Blood
Blood (2015) 126 (23): 5634.
https://doi.org/10.1182/blood.V126.23.5634.5634
Published: 2015
Journal Articles

Fluid-Related Complications in Patients with Amyloidosis Associated with Filgrastim during Peripheral Blood Stem Cell Mobilization.

Julianna A. Burzynski, PharmD, Angela Dispenzieri, MD, Morie A. Gertz, MD, Martha Q. Lacy, MD, Tanya L. Hoskin, MS, Robert C. Wolf, PharmD
Journal: Blood
Blood (2004) 104 (11): 1143.
https://doi.org/10.1182/blood.V104.11.1143.1143
Published: 2004